Raltegravir Pharmacokinetics and Safety in Neonates
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms IMPAACT-P1097
- 04 Oct 2017 Planned primary completion date changed from 1 Aug 2019 to 1 Dec 2018.
- 26 Aug 2014 Interim results (n=22) published in the JAIDS.
- 24 Apr 2013 New trial record